Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
05:17:11 EST Wed 11 Feb 2026
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR+ Search
SEDAR+ Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR+ Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login ID:
Password:
Save
Q:DTCFF
- DEFENCE THERAPEUTICS INC -
Website unknown - click to update
05:17:11 EST
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
DTCFF
- Q
not subscribed
0.4482
-0.0118
-2.6
2.3
1
6
0.4405
0.4482
0.4405
1.1575 0.3446
Feb 10
Feb 10
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
OTC Markets Indicators -- Primary Market:
OTC Markets
-- Tier:
OTCQB
-- Status:
Active
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Portfolio
Recent Trades - All 6 today
More trades...
Time ET
Ex
Price
Change
Volume
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2026-02-10 03:16
U:DTCFF
News Release
200
Defence Therapeutics Aligns Accum ADC Strategy Through Multidisciplinary Scientific Advisory Board
2026-02-04 03:16
U:DTCFF
News Release
200
Defence Therapeutics to Present at the World ADC Europe 2026 Showcasing Accum Precision Intracellular Drug-Delivery Platform
2026-01-28 08:41
U:DTCFF
News Release
200
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
2026-01-21 03:16
U:DTCFF
News Release
200
Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics
2025-12-11 08:35
U:DTCFF
News Release
200
Defence Therapeutics to Present at the Life Sciences Virtual Investor Forum December 11th
2025-12-10 16:31
U:DTCFF
News Release
200
Defence Therapeutics Announces AGM Results and Provides Corporate Updates
2025-12-04 03:17
U:DTCFF
News Release
200
Defence Therapeutics Announces Formation of Scientific Advisory Board to Guide Advancement of Accum-Enhanced Antibody Drug Conjugate Programs
2025-11-21 18:04
U:DTCFF
News Release
200
Defence Therapeutics Announces Convertible Debenture Conversion
2025-11-19 03:16
U:DTCFF
News Release
200
Defence Therapeutics to Build ADC Drug Delivery Powerhouse Using Its Proprietary Accum Technology
2025-11-06 03:17
U:DTCFF
News Release
200
Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs
2025-11-04 03:16
U:DTCFF
News Release
200
Defence Therapeutics Demonstrates Strong Preclinical in Vivo Efficacy Results Evaluating Accum-Kadcyla in Breast Cancer Models
2025-10-23 03:16
U:DTCFF
News Release
200
Defence to Present New Scientific Data on Its ADC-Enhancing Accum Technology at the World ADC Conference in San Diego, USA, November 4-5, 2025
2025-10-06 03:16
U:DTCFF
News Release
200
Defence Therapeutics to Attend CPHI Worldwide in Frankfurt, October 28-30, 2025
2025-10-02 03:16
U:DTCFF
News Release
200
Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations
2025-09-23 09:16
U:DTCFF
News Release
200
Defence's Director, Strategy & Business Advisor Dr. Amie Phinney Discusses the Accum Platform on Money Talk Radio with Ellis Martin
2025-09-23 03:03
U:DTCFF
News Release
200
Ellis Martin Report: Dr. Amie Phinney of Defence Therapeutics Inc. (DTCFF) on the Accum(TM) Platform
2025-09-16 03:16
U:DTCFF
News Release
200
Defence Therapeutics Appoints Dr. Amie Phinney as Director
2025-09-15 16:31
U:DTCFF
News Release
200
Defence Therapeutics Completes Fully Subscribed Debenture Units Financing of $2,000,000
2025-09-02 03:16
U:DTCFF
News Release
200
Defence Therapeutics Engages Dr. Amie Phinney as Strategy & Business Advisor to Guide Next Phase of Growth
2025-08-22 20:31
U:DTCFF
News Release
200
Defence Therapeutics Announces Debenture Units Financing